GLOBUS MEDICAL INC (GMED) is a publicly traded Healthcare sector company. As of August 19, 2026, GMED trades at $88.36 with a market cap of $11.61B and a P/E ratio of 116.59. GMED moved +2.20% today. Year to date, GMED is +1.19%; over the trailing twelve months it is +44.42%. Its 52-week range spans $51.79 to $101.40. Analyst consensus is strong buy with an average price target of $102.20. Rallies surfaces GMED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest GMED news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $88.36 |
| Market Cap | $11.61B |
| P/E Ratio | 116.59 |
| EPS | $0.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $101.40 |
| 52-Week Low | $51.79 |
| Volume | 863.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.52B |
| Net Income | $102.98M |
| Gross Margin | 58.90% |
12 analysts cover GMED: 0 strong buy, 9 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $102.20.